fashion -WSS

fashion

author：knowledge 2025-09-28 23:47:34 - browse：338

A heart monitoring watch, referred as Project Zero 2.0 is displayed in the Omron Healthcare booth during a press event – health tech coverage from STAT — Digital tools to better track blood pressure over time and encourage adherence to treatment plans are increasingly commonplace. David Becker/Getty Images

If you have high blood pressure, it’s increasingly likely that your doctor or your insurer will offer you a blood pressure cuff or an educational app to help you get it under control. While potentially impactful, these tools may not be reaching marginalized people who don’t regularly have access to good health care — and who may benefit the most from the tools.

A new analysis suggests that there ought to be more investment in novel hypertension programs for people experiencing health disparities.The meta-review of 28 studies of digital health interventions for people of color and low-income patients found that as a whole participants saw a statistically significant and clinically meaningful reduction in average systolic blood pressure compared to control groups. In total, the analysis included more than 8,000 participants; most of the studies followed participants for six or 12 months. The results, published Wednesday in JAMA Network Open, are consistent with studies of digital tools in the general population.

Joseph Ebinger, of the Smidt Heart Institute at Cedars-Sinai in Los Angeles, who was not involved in the study, said it provides needed evidence that “there are tools that exist to be able to help meet individuals where they are in the world, and they should be utilized more heavily.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Study: Why relieving medical debt did not improve financial outcomes

knowledge

leisure time

WSS

How faith leaders like me can help address America's obesity epidemic

Statins may not be needed by millions of people, study suggests

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

STAT Virtual Event: ASCO Recap, Live!

New report analyzes digital physical therapy solutions' effectiveness

knowledge

fashion

explore

The high cost of giving birth even with insurance

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Medical leaders decry Supreme Court decision on affirmative action

Cancer thrives by mutating. But sometimes, a mutation leaves it vulnerable

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Affirmative action in medical school literally saved lives

Coercive sterilizations revealed by STAT prompt outrage

focus

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Cheap, fast test for Zika and dengue could cost just $1

FDA's Woodcock to retire early next year

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Ransomware attacks on hospitals: Study outlines patient impact

Cigna wins case to block Amy Bricker's move to CVS

knowledge

entertainment

leisure time

leisure time